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Abstract
We propose to synthesize and characterize magnetic microbubbles for examining the use of magnetic
microbubbles for targeted drug delivery. Using magnetic microbubbles as carriers, we will test how well
drugs can be dispersed by means of ultrasound and hyperthermia.

Statement of Activity
Overview of Award Activity
In this project we proposed to answer the research question: Can magnetic microbubbles (MMB) be
used to enhance drug delivery? To do this, we have successfully synthesized magnetic nanoparticles (MNP),
coated them with surfactant, characterized them with respect to material and size distribution, integrated the
MNP into MMB, and characterized the MMB.
We found that MNP synthesis was more challenging than the literature suggested. We used a standard
co-precipitation method, but were getting inconsistent results and often failures. After a few months of refining
our technique we determined that performing our synthesis under a non-oxidizing environment was a key factor
in successfully synthesizing Fe3O4 MNP, which was the first key goal for the project.
Having made the particles, we then needed to coat them with a surfactant to prevent their agglomeration
and enable them to be made into a biocompatible solution that can be integrated into microbubbles. We chose
dextran first because of its excellent biocompatibility, wide availability, and water-solubility. Coating with
dextran also proved to be a challenge at first and particles would fall out of solution. Eventually we determined
that using a higher powered probe sonicator enabled much better coating compared with the original bath
sonicator. However, we were still unable to form MMB with dextran-coated MNP.
We then investigated the use of oleic acid to coat the particles. Our hypothesis was that oleic acid would
be better for MMB integration than dextran because it was hydrophobic. We found that coating the MNP with
oleic acid was simpler than the dextran coating and we carried it out successfully. We are still investigating the
comparative properties of MMB with dextran-coated MNP versus MMB with oleic acid-coated MNP.
Given the multiple difficulties associated with the synthesis of the MNP and thus MMB, we have not yet
functionalized the MNP so that a model drug can be attached. The original proposal proposed functionalizing
dextran-coated particles, but the chemical functionalization of oleic acid is different. We are currently
investigating how this might be performed.
Nicolaas Winter proposed the original project. Prior to his graduation in the Spring 2014, Nathaniel
Mosher and Emily Perkins-Harbin began working as the primary student researchers with additional
participation by Brandon Aho (Physics), Natalie Gerdung (Chem. Eng.), and Denis Volobuev (Biology). The
three primary student researchers were members of SPS National and four of the students were participants in
our local Physics Club. Several more students will be continuing work on magnetic nanoparticles and
microbubbles in the coming year. A side project to build an enclosure unit for the ultrasonic probe sonicator
involved an additional three students, one of whom was a member of SPS National and our local Physics Club.

Description of Research - Methods, Design, and Procedures
Nanoparticles. We have, after many trials and refinements, successfully synthesized dextran-coated iron
oxide (Fe3O4) magnetic nanoparticles via a chemical co-precipitation method.1,2 This method, briefly, involves
the addition of a strong base in excess to a solution containing a 1:2 molar ratio of Fe2+:Fe3+ ions under a nonoxidizing atmosphere. The overall chemical reaction is described by:
Fe2++2Fe3++8OH− → Fe3O4 + 4H2O
The addition of the base causes bare Fe3O4 nanoparticles to precipitate out of solution, at which point they are
washed and decanted. We then add the bare nanoparticles to a basic solution with the surfactant (dextran) and
expose it to ultrasonic radiation (via an ultrasonic probe sonicator) until the dextran is fully adsorbed onto the
surface of the nanoparticles. Dextran allows the nanoparticles to remain stable in aqueous solution because it
provides steric repulsion between each nanoparticle, thereby preventing agglomeration and precipitation. It also
enhances the nanoparticles’ biocompatibility, which is crucial for biological applications. We characterize the
resulting MNP using x-ray diffraction and transmission electron microscopy (TEM) to determine phase and size
distribution. We also prepare samples for magnetic characterization via SQUID magnetometry.
When a MNP fluid is placed in an alternating magnetic field, the fluid will heat up as a result of energy
dissipated from physical rotation of the particles (Brownian relaxation) and changes in the directions of the
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particles’ internal magnetic domains (Néel relaxation), a phenomenon called magnetic fluid hyperthermia
(MFH). To characterize the hyperthermic response of the MNP, we use an Ambrell induction system, which
runs an alternating current through a coil to create an alternating magnetic field, thereby heating the MNP
sample placed within the coil. The system can be adjusted to output different frequencies and magnetic field
strengths. An optical thermometer placed in the MNP sample is used to measure the heat generated from MFH.
The sample is insulated to minimize heat transfer to the environment, which affects the apparent heating rate.
Any heat transfer not eliminated is accounted for in the heating rate calculation. We also investigated the
physical mechanisms responsible for MFH by building an apparatus to enable the ferrofluid to be frozen into a
“ferrosolid” by submerging the ferrofluid in liquid nitrogen until it froze completely. We then apply an
alternating magnetic field to the frozen sample and compare the heating rates to those of liquid samples.
Microbubbles. We created control (non-magnetic) microbubbles by mixing magnetic nanoparticles and
L-α-phosphatidylcholine into a phosphate-buffered saline solution. The microbubbles formed via exposure to
the probe sonicator for 30 s, following by manual shaking for 30 s. For the creation of magnetic microbubbles,3
we repeat the process with the addition of the magnetic nanoparticles and another sonication step.
We characterize the MMB primarily by viewing under a microscope. By placing the MMB in a
hemocytometer with known scale markings, we are able to determine the size distribution. To test whether the
MMB are actually magnetic, a 30 mT bar magnet is placed by the microscope slide containing the MMB, and
they are viewed to see if they respond to the field.

Discussion of Results
Nanoparticles. Through x-ray diffraction, we found that the MNP were composed of Fe3O4 and Fe2O3,
as expected. Figure 1 shows TEM imaging of a typical MNP sample, revealing that the particle size ranges from
5‒20 nm, which is well within the range of a superparamagnetic single domain material. Magnetic
characterization experiments are planned at an off-campus location during early 2015.
We measured the hyperthermic ability of the MNP by exposing them to alternating magnetic fields of
various frequencies. The heating rates of the MNPs were then calculated for each frequency to determine their
efficacy, as described in the midyear report. The effectiveness of the heating suggests that thermally-induced
drug release from the MNP is at least plausible. We also investigated heating mechanisms of the MNP by
comparing the heating rate between liquid (Brownian and Néel relaxation) and frozen states (only Néel
relaxation). Figure 2 shows the temperature of the sample as a function of time for a frozen sample. We find
that frozen MNP typically heat at a reduced rate as compared to the liquid MNP, which makes sense because
the Brownian motion is reduced or even completely suppressed by the immobilization of the MNP due to the
freezing. A liquid sample heated under the same conditions as those seen in Fig. 2 would therefore have a
steeper slope. Analysis of data and calculation of specific absorption rates (SAR in J/g) for multiple frequencies
between 150 kHz and 350 kHz is ongoing and will be reported at the 2015 APS March Meeting.
To determine the bioeffects of the MNP, a proof-of-concept experiment was run in cooperation with Dr.
Hakan Demerci of the University of Michigan Kellogg Eye Center for retinoblastoma cells cultured in vitro to
determine cytotoxicity levels and the ability of MFH to induce cell death. We found that a majority of the cells
were killed after exposure to MFH up to 50 . Future work is planned to test the MNP in an animal model to
get results more representative of what we could expect in the human body.
Microbubbles. The microbubbles created with the MNP were visibly darker than the plain microbubbles,
both macro- and microscopically. The color difference was taken as an indication that the MNP were
incorporated with the bubbles. When placed in a field, as in Fig. 3, the MMB can be seen forming chains
parallel to the field, suggesting that the bubbles are magnetic. These bubbles averaged 5 μm across.
Microbubbles that did not contain MNP did not respond to the field.
We found that we had better incorporation of the MNP into the microbubbles with oleic-acid-coated
MNP than with dextran-coated MNP. We believe that this could be because the phosphatidylcholine forms a
lipid monolayer with the hydrophobic tails directed in towards the air at the center of the bubble. Consequently
the hydrophobic oleic-acid-coated nanoparticles are likely traversing the monolayer to congregate near the lipid
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tails to minimize contact with the water. It is also possible that the bubbles are formed of lipid bilayers, and that
the oleic acid nanoparticles will congregate between the layers for the same reason.

Dissemination of Results


Each spring the Kettering University sponsors a “Homecoming” event for alumni to come back to campus.
As part of this event, the university organizes a poster session for students, faculty, and staff to present their
activities. We presented two posters related to the current project on 17 May 2014:
o E. Perkins-Harbin, N. Mosher, R. Cunningham, L. Wang, P. Vaishnava, R. E. Kumon, “Magnetic
Microbubbles for Biomedical Applications”
o N. Mosher, N. Winter, E. Perkins-Harbin, N. Gerdung, R. Cunningham, C. Rablau, L. Wang,
R. E. Kumon, P. Vaishnava, “Synthesis and Characterization of Biocompatible Magnetic Nanoparticles”
 We also presented these posters at the Wayne State University 8th Annual Undergraduate Research
Conference on 7 November 2014 and Discover Kettering, a recruiting day for high school students, on 8
November 2014. The posters have been on display in the hallway outside of our lab since May 2014.
 We were involved in the production of a video entitled “Magnetic Nanoparticles and Microbubbles” as part
of Kettering University’s “Making a Better World” series. The video features Prof. Ronald Kumon, Prof.
Prem Vaishnava, Nathaniel Mosher, and Emily Perkins-Harbin and was distributed via the Kettering
University YouTube channel (https://www.youtube.com/watch?v=IJ2qi15jOaQ). It had 402 views as of 31
December 2014.
 Emily Perkins-Harbin also made a presentation to her Medical Physics class on 16 December 2014, entitled
“Enhancing Cancer Treatment with Magnetic Fluid Hyperthermia,” which was open to the public.
 We co-authored an abstract that has been accepted for an oral presentation to the 2015 APS March Meeting:
N. Mosher, E. Perkins-Harbin, B. Aho, L. Wang, R. Kumon, P. Vaishnava; R. Tackett, “Determination of
the magnetocrystalline anisotropy constant from the frequency dependence of the specific absorption rate in
a frozen ferrofluid”
 Two senior theses are currently in preparation, with anticipated completion by April 2015:
o Emily Perkins-Harbin, “Synthesis and Characterization of Magnetic Microbubbles”
o Nathaniel Mosher, “Drug Delivery using Magnetically-Induced Hyperthermia and Ultrasound”
Examples of disseminated results are included in Appendix A.
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Impact Assessment:
How the Project Influenced your Chapter
This experience was very much worthwhile and exposed many members of our SPS chapter to many
valuable experiences and created many opportunities. One of the biggest lessons we learned was that learning to
work with an interdisciplinary group is invaluable. Our project extends beyond physics to chemistry and even
biology. As such, we have had the pleasure to work with people and subject matter that we are not normally
exposed to in physics education and came out better for it.
This work involved work from many members from our SPS chapter and that meant working closely
with each other for a good length of time. We came to know each other a lot better as a result. Additionally,
because of our close work with faculty from the entire university, the SPS chapter’s ties with faculty also
became much stronger.
Additionally, simply being exposed to research in a university setting has given us a real taste of what
academic research is like. Also, we are now familiar with the processes vital to academic research such as
publishing papers, data management, presenting scientific results, etc. As a result, several members are actively
pursuing graduate school where before they may not have.
Our advice to other SPS chapters: don’t be afraid to work with subject matters other than physics; work
as an interdisciplinary team and everybody will be better for it.

Key Metrics and Reflection
How many students from your SPS chapter were involved
in the research, and in what capacity?

Was the amount of money you received from SPS
sufficient to carry out the activities outlined in your
proposal?
Could you have used additional funding? If yes, how
much would you have liked? How would the additional
funding have augmented your activity?
Do you anticipate continuing or expanding on this
research project in the future? If yes, please explain.

If you were to do your project again, what would you do
differently?
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Six students were involved in the main research
project, four of which were active members of the
local club. These students wrote the proposal,
synthesized nanoparticles and microbubbles, and
characterized the nanoparticles and microbubbles,
and performed experiments on nanoparticle
heating. An additional three students were
involved in a side project.
The amount of funding was sufficient for some of
the basic supplies and equipment, but additional
funding was needed to cover the costs of some of
the more expensive equipment and basic
laboratory supplies, as noted in the Expenditures
section.
Yes, this project is still ongoing and we anticipate
it will continue for some time. More research can
be done exploring the structure as well as the
effect that different nanoparticle coatings and
different lipid chain lengths have on the
characteristics of the bubbles.
Having a better idea of the time and complexity of
the initial steps would have helped planning the
next steps.

Press Coverage (if applicable)
One of the projects that we were involved in was testing of the use of magnetic nanoparticles for killing ocular
cancer cells in vitro in collaboration with Kellogg Eye Center at the University of Michigan in Ann Arbor. This
work received coverage via local media and social media:
 Kettering University News, “Kettering, University of Michigan researchers partner to transform ocular
cancer treatment” by Pardeep Toor, 29 October 2014,
http://www.kettering.edu/news/kettering-university-michigan-researchers-partner-transform-ocular-cancertreatment
 Google Plus posting, Kellogg Eye Center, 30 October 2014,
https://plus.google.com/+kelloggeyecenter/posts/fmoTgpd3TyT
 DBusiness Daily News, “Kettering, U-M researchers treating ocular cancer without radiation,” 07
November 2014,
http://www.dbusiness.com/daily-news/Annual-2014/Kettering-U-M-Researchers-Treating-Ocular-Cancerwithout-Radiation/
 MLive.com, “Kettering University professor helps develop new technique to fight ocular cancer” by Sarah
Schuch, 12 November 2014,
http://www.mlive.com/news/flint/index.ssf/2014/11/kettering_university_professor_14.html
 University of Michigan Kellogg Eye Center 2014‒15 Annual Report, “Collaborations in ocular oncology:
Using thermal energy to eliminate side effects in eye cancer therapies,” p. 15, available at
http://issuu.com/u-mkelloggeyecenter/docs/ar_2014_055b4d66b24bfc?e=6943966/10813102
Examples of this press coverage are included in Appendix B.
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Expenditures
Expenditure Table
Item
Mesh basket for ultrasonic bath
Hemacytometer
(phase-contrast, bright-line)
Adjustable Pipettor (0.5 to 10 μL),
Adjustable Pipettor (10 to 100 μL),
Adjustable Pipettor (100 to 1000 μL)
Iron (II) Chloride Tetrahydrate,
Iron (II) Chloride Tetrahydrate,
Sodium hydroxide concentrate,
Ammonium hydroxide solution,
Hydrochloric acide solution,
Oleic acid
Dextran (low fraction)
Fluorescein isothiocyanate (FITC),
Epichlorohydrin
Separatory funnel

Dialysis device
Phosphatidylcholine

Please explain how this expense relates to
your project as outlined in your proposal.

Cost

The mesh basket is used to hold the
magnetic nanoparticle samples during the
coating process.
The hemacytometer are used to size and
count the magnetic microbubbles.
The adjustable pipetters are used to
dispense liquids during magnetic
nanoparticle and microbubble synthesis
and characterization.
These chemical supplies are used to
synthesize magnetic nanoparticles, except
for the oleic acid. The oleic acid is used to
create a hydrophobic coating for the
magnetic nanoparticles.

$81.08

Dextran is used to create a hydrophilic
coating for the magnetic nanoparticles to
make them stable in an aqueous solution.
These supplies are used to functionalize
the coatings on the magnetic
nanoparticles (i.e., to cross-link and
florescently label them).
The funnel is custom-made glassware
used to synthesize the magnetic
nanoparticles.
Dialysis devices are used to remove
excess sodium hydroxide introduced in the
synthesis procedure of the magnetic
nanoparticles.
This phospholipid is used to create the
shell around the magnetic microbubbles.
Slight overage covered by external
support

Total of Expenses Covered by SPS Funding

$179.93
$559.80

$410.69

$132.46
$107.68

$258.86
$108.90

$205.85
($48.25)

$1997.00

Note: The figures shown in this final expense report may differ slightly from the midyear
report, as these final figures account for the total costs including shipping and handling.
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Significant support for this project was covered by other sources of funding from Kettering
University to faculty advisors (Prof. Ronald Kumon, Prof. Prem Vaishnava):
Item
Ultrasonic bath sonicator
Probe sonicator

Sound enclosure
Microscope slides & cover slips
Benchtop protectors
Immersion oil for microscope
Phosphatidylcholine
(hydrogenated & from egg yolk)
Phosphate-buffered saline (PBS)
tablet and 10X solution
Refrigerator/freezer
Nitrile gloves
(small, medium, & large)

Sharps container

Digital thermometer
Beakers & graduated cylinders
Pasteur pipettes & dropper bulbs
Wash bottles
Microcentrifuge tube rack

Please explain how this expense relates to
your project as outlined in your proposal.

Cost

The bath sonicator is used to more gently
coat magnetic nanoparticles than the
The probe sonicator is used to disperse
magnetic nanoparticles and create
magnetic microbubbles.
This hand-made enclosure is used to
reduce the loud, high-pitched sound
generated by the probe sonicator for
occupational health & safety.
Microscope slides and cover slips are used
to view magnetic microbubbles.
These protectors are used to protect the
benchtops from chemical spills.
This oil is used to view magnetic
microbubbles under a high magnification
oil-immersion microscope objective.
This phospholipid is used to create the
shell around the magnetic microbubbles.
These supplies are used to create an
aqueous solution that is osmotically
balanced for use with cells.
This small refrigerator/freezer is used to
store chemical supplies.
These gloves are used during the synthesis
of the magnetic nanoparticles and
microbubbles for occupational health &
safety.
The sharps containers are used during
synthesis of the magnetic nanoparticles
and microbubbles to collect broken glass
or other sharp metal tips.
The thermometer is used to monitor
temperature of the solution during
nanoparticle synthesis.
This glassware is used during the
synthesis of magnetic nanoparticles.
These pipettes are used during the
synthesis of magnetic nanoparticles.
These bottles are used to clean glassware
and provide water during experiments.
These racks are used to hold the
microcentrifuge tubes used to hold the
magnetic nanoparticles samples.
8

$828.00
$2250.00
$90.88

$5.25
$37.22
$8.50

$126.50
$86.55
$119.00
$114.04

$4.86

$18.38
$183.97
$62.38
$42.42
$26.81

Paraffin wrapping film
Wipes
pH paper

pH sensor & storage solution
Labelling tape
Magnetic retreiver

Weighing dishes (small & large)

Chemical waste containers

Transmission electron microscope
user fees

Poster printing

This film is used to seal containers as part
of the magnetic nanoparticle synthesis
The wipes are used to clean up minor
spills during experiments
This paper was used during the early
magnetic nanoparticle synthesis
procedures to intermittently estimate pH
of the solution.
The pH meter was used during the later
magnetic nanoparticle synthesis
procedures to continuously measure pH of
the solution.
This tape is used to label samples of
magnetic nanoparticles & microbubbles.
The retreiver is used to retrieve the
magnetic stir bar used during parts of the
magnetic nanoparticle synthesis.
The dishes are used to weigh out
powdered chemical supplies during the
magnetic nanoparticle synthesis &
characterization.
The containers are used to dispose of
waste products from the magnetic
nanoparticle and microbubble synthesis.
These fees were paid to a transmission
electron microscope user facility at
Michigan State University to characterize
the size and shape of the magnetic
nanoparticles.
The university covered the cost of printing
two posters to be presented at the annual
Homecoming poster session.
Slight overage covered by external
support

Total of Expenses Covered by Other Support

Expenditure Table
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$20.83
$4.46
$10.09

$98.58

$5.06
$8.88
$110.53

$5.36
$150.00

$60.00
$48.25

$4607.88

Activity Photos

Figure 1. TEM image of MNP coated with dextran. [Image by X. Zhou]
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Figure 2. Heating curve of frozen ferrofluid undergoing magnetic fluid hyperthermia with magnetic field
oscillating at 150 kHz. [Figure by Nathaniel Mosher]
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Figure 3. The left image shows magnetic microbubbles forming chains as they align with the magnetic field,
indicated by the arrow. The right image shows the same bubbles without a magnetic field. The large, dark spots
are clusters of excess nanoparticles that did not join with the bubbles. The images were taken at 20X
magnification. [Images by Emily Perkins-Harbin]
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Appendix A: Examples of Disseminated Products
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Targeted Drug & Gene Delivery
• Microbubbles exposed to ultrasound can cause sonoporation, or
transient increase in cell membrane
permeability.
• Pores can be
opened by shear
stresses from
oscillation and
collapse of
[Image from A. Delalande et al.,
Bubble Sci. Engin. Technol. (2011)]
microbubbles.
• Ultrasound allows for spatial &
temporal control of delivery.
• Side effects of treatment may be
reduced and more healthy tissue
spared.
Hyperthermia
• Magnetic nanoparticles in an
oscillating magnetic field will heat
up surrounding medium.
• Heat can induced drug release &
increase drug efficacy or even
directly kill cancer cells.
• Heat produce by the nanoparticles
can be controlled to reduce damage
to healthy cells.

Potential Applications

Magnetic Microbubbles (MMB)
• MMB are
microbubbles
with magnetic
nanoparticles
embedded in
the coating.
• Combines
useful acoustic
and magnetic
properties of
[Image from X. Cai et al.
both agents.
Theranostics (2012)]

Nanoparticles
• Particles typically
between 1‒100 nm.
• They are used for
drug delivery and
cancer treatment.
• Because of their
small size, they can
penetrate biological
barriers well.
Suspension of
• We used iron oxide
iron oxide
nanoparticles
nanoparticles for
magnetic properties.

Microbubbles
• Bubbles typically
between 1 μm
and 1 mm in diameter.
• Clinically they are used primarily
as an ultrasound contrast agent.
• They are hard to direct in the body.
• We coated them with a surfactant
(phospholipid) to increase lifespan.

2Department

Both microbubbles and magnetic
nanoparticles have been used in
medical applications. Combining
them creates additional benefits and
new applications. This project
explores the creation and use of
magnetic microbubbles with a goal
of targeted cancer treatment.

of Physics

Background

1Department

Figure 1: Sonication of microbubblenanoparticle mixture with 3 mm
probe driven at 20 kHz.

Magnetic Microbubbles
• Fe3O4 nanoparticles added to
microbubbles
• Sonicated for 30 seconds
• Shaken for 30 seconds

Microbubbles
• L-α-phosphatidylcholine added to
phosphate-buffered saline
• Sonicated for 30 seconds
• Shaken for 30 seconds

Fe3O4 Nanoparticles
• Fe(II)Cl2 and Fe(III)Cl3 are
coprecipitated

Results

Ronald E. Kumon, rkumon@kettering.edu
Prem Vaishnava, pvaishnava@kettering.edu
Department of Physics, Kettering University
1700 University Ave, Flint, Michigan 48375

Contact Information

Funding was provided by:
• Society of Physics Students
Sigma Pi Sigma Undergraduate
Research Award
• Kettering University Faculty
Research Fellowship (R.E.K. & P.V.)

Acknowledgments

Characterization
• Sizing
• Lifespan
• Density of nanoparticle coating
• Ultrasonic properties
Drug Delivery
• Attach model drug to MMBs.
• Repeat characterization.
• Testing drug-loaded MMBs in vitro.

Future Work

Figure 2: Magnetic microbubbles

Kettering University, Flint MI

Methods

of Chemistry/Biochemistry

Perkins-Harbin, 1N. Mosher, 1R. Cunningham, 2L. Wang, 1P. Vaishnava, 1R. E. Kumon

Abstract

1E.

Magnetic Microbubbles for Biomedical Applications

Fe3O4
Nanoparticle

Dextran
Molecule

• Fe3O4 (iron oxide) is one of the
most promising and popular MNP
choices
– Superparamagnetic (130nm)
– High saturation magnetization
– Able to be functionalized and
coated in many ways
– Surfactant required for stability

• For biological use, MNPs should:
– Be non-toxic and biocompatible
– Have a modifiable surface
– Have high magnetization values
– Have narrow size distributions
– Be able to cross biological
barriers

Introduction

Overall chemical reaction:
Fe2++ 2Fe3++ 8OH  Fe3O4 + 4H2O

• Traditional chemotherapy has
undesirable systemic side effects.
• Magnetic nanoparticles (MNPs) can
be remotely-activated to kill cells
using magnetically-induced heating
and/or drug release only where
treatment is needed.
• Project Goal:
Create & characterize MNPs for
targeted treatment of cancer

Biocompatible,
superparamagnetic
Fe3O4 MNPs are
obtained.

Mix Fe3O4 particles with
NaOH and dextran

Sonicate until
colloid becomes
stable

Fe3O4 nanoparticle

dextran

Decant and rinse
until pH 7.

Black precipitate will
settle.

Drip NH3OH into Fe
solution until
pH ~11.

Create aqueous
mixture of
Fe2+ and Fe3+ chloride
at 1:2 molar ratio.

Synthesis: Fe3O4 + Dextran

Motivation

of Physics 2Department of Chemical Engineering
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• When MNPs are placed in an
alternating magnetic field, they try to
align with their field by rotating their
internal magnetic moment or
physically rotating in space.
• Both processes result in heating of
the surrounding medium.

AC Magnetic Induction

• Method to determine crystalline
structure by scattering of x-rays
from nanoparticle powder
• Diffraction peaks are consistent
with Fe3O4:

X-ray Diffraction (XRD)

Prem Vaishnava, pvaishnava@kettering.edu
Ronald E. Kumon, rkumon@kettering.edu
Department of Physics, Kettering University
1700 University Ave, Flint, Michigan 48375

Contact Information

Funding was provided by:
• Society of Physics Students
Sigma Pi Sigma Undergraduate
Research Award
• Kettering University Faculty
Research Fellowship (R.E.K. & P.V.)

Acknowledgments

• Synthesize Fe3O4 with oleic acid
coating & compare with dextran.
• Characterize MNPs further:
– Saturation magnetization
– Size distribution by Transmission
Electron Microscopy (TEM)
• Cross link and functionalize dextran.
• Optimize particle size and
concentration for hyperthermia.
• Attach anti-cancer drug doxorubicin.
• Develop drug releasing mechanisms.
• Test magnetic nanoparticles in
cancer cell cultures in vitro

Future Work

• Fe3O4 nanoparticles have been
synthesized by a co-precipitation
method.
• XRD shows MNPs are crystalline &
in the size range expected.
• AC induction shows that Fe3O4 is
viable for hyperthermia.

Results & Conclusions

of Chemistry/Biochemistry Kettering University, Flint, Michigan

Characterization

3Department

Mosher, 1N. Winter, 1E. Perkins-Harbin, 2N. Gerdung, 1R. Cunningham, 1C. Rablau, 3L. Wang, 1R. E. Kumon, 1P. Vaishnava

1Department

1N.

Synthesis and Characterization of
Biocompatible Magnetic Nanoparticles

Temperature (°C)

Enhancing Cancer Treatment with
Magnetic Fluid Hyperthermia (MFH)

Emily Perkins‐Harbin
Phys 354 ‐ Medical Physics
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(Lockwood, 2011)

MFH as a cancer treatment option may have significant
advantages over current treatments
Current treatments can be improved upon

How does MFH work?
(Nanoprobes.com, 2014)

Applications/Research
(Seniorscientific.com, 2014)
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The problem: Chemo and radiation therapy kill healthy
cells which can lead to serious side effects

Chemotherapy

Radiation therapy

(Martino et al., 2013)

(Online Degrees, 2013)

Hyperthermia uses heat to kill cells
°C

(Autoren, 2014)
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We can use magnetic nanoparticles to provide
targeted heating, limiting side effects

Fluorescing
Nanoparticles
Tumor

(Yuan et al., 2014)

The heat generated is used to kill cancer

(Hayashi et al., 2013)
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(Lee et al., 2011)

The magnetic fluid used in MFH is comprised of
magnetic nanoparticles
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Nanoparticles are so small they only have one
domain

Nanoparticles align with a magnetic field in two
different ways
Neel

Brownian

B
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Treatment of prostate with MFH is currently in
human trials in Germany

(Johannsen et al., 2006)

There is research being done on using MFH to treat GBM, a
very deadly tumor with no other form of treatment

(Mahmoudi and Hadjipanayis, 2014)
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In conclusion, MHF has the potential to replace or enhance
the current methods of treating cancer

Targeted means that only
cancer cells get killed
Fewer side effects
Enormous number of
research paths to explore
(Seniorscientific.com, 2014)
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Determination of the magnetocrystalline anisotropy
constant from the frequency dependence of the specific absorption rate in a frozen ferrofluid1 NATHANIEL MOSHER,
EMILY PERKINS-HARBIN, BRANDON AHO, Kettering University
Department of Physics, LIHUA WANG, Kettering University Department of Chemistry and Biochemistry, RONALD KUMON, CORNELIU RABLAU, PREM VAISHNAVA, RONALD TACKETT, Kettering University Department of Physics, THERAPEUTIC BIOMATERIALS GROUP TEAM — Colloidal suspensions of superparamagnetic
nanoparticles, known as ferrofluids, are promising candidates for the mediation of magnetic fluid hyperthermia (MFH). In such materials, the
dissipation of heat occurs as a result of the relaxation of the particles
in an applied ac magnetic field via the Brownian and Neel mechanisms.
In order to isolate and study the role of the Neel mechanism in this
process, the sample can be frozen, using liquid nitrogen, in order to
suppress the Brownian relaxation. In this experiment, dextran-coated
Fe3 O4 nanoparticles synthesized via co-precipitation and characterized
via transmission electron microscopy and dc magnetization are used as
MFH mediators over the temperature range between -70 ◦ C to -10 ◦ C
(Brownian-suppressed state). Heating the nanoparticles using ac magnetic field (amplitude ∼300 Oe), the frequency dependence of the specific
absorption rate (SAR) is calculated between 150 kHz and 350 kHz and
used to determine the magnetocrystalline anisotropy of the sample.
1 We
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Kettering, University of Michigan researchers partner
to transform ocular cancer treatment
Oct 29, 2014

"We have documented proof that our procedure would kill cancer cells without
using chemotherapy and/or radiation.”

Dr. Prem Vaishnava is working on a new technique to treat ocular cancer.

A newfound partnership between Dr. Prem Vaishnava, professor of Physics at Kettering
University, and Dr. Hakan Demirci at the University of Michigan Kellogg Eye Center is
attempting to forever change the treatment of ocular cancer in the United States through
a targeted and precise technique that has proven to mitigate the disease without the
side effects of chemotherapy and radiation.
“We are confident our technique would work because we have results of preliminary
testing in a petri dish,” Vaishnava said. “We have documented proof that our procedure
would kill cancer cells without using chemotherapy and/or radiation.”
The treatment uses magnetic nanoparticles and magnetic microbubbles to specifically
target Chorodial Melanoma and Retinoblastoma – both cancers of the eye. This
technique is currently being used to treat cancer in humans in Europe but has not yet
been approved in the United States.

“The science is there and there’s proof that it works. Phase I and Phase II trials have
been conducted successfully using magnetic nanoparticles in animals in the United
States,” Vaishnava said.
How It Works
Demirci is an oncology specialist at the Kellogg Eye Center in Ann Arbor. He reached
out to Vaishnava to express his interest in using magnetic nanoparticles and
hyperthermia to treat eye cancer. In a simple experiment, retinoblastoma cancer cells
were mixed with magnetic nanoparticles in a petri dish and the mixture was exposed to
an alternating magnetic field of frequency 350 kHz. The magnetic nanoparticles
produced heat which is sufficient to kill cancer cells and the healthy cells remain
unharmed.
Related:
In several instances heat is also provided by
microware. Vaishnava explains that this treatment Using nano-technology to treat cancer
can be a bit “nasty” because an antenna is needed NSF grant will help Kettering acquire
to be placed underneath the skin near the eye ball X-Ray diffractometer
to heat the tumor. The procedure burns the skin and tissues during the installation of the
antenna. Magnetic nanoparticles do not have such side effects.
Magnetic nanoparticles are iron oxide molecules that are suspended in a solution and
can be injected into the body or directly into tumor without any harm. Once injected,
particles disperse randomly, however, what Vaishnava has determined that if a magnet
is positioned around the region where the cancer is located in the eye, the magnetic
nanoparticles will be attracted to that site. Once they are concentrated around the the
cancer site, a magnetic field can be applied which will cause the nanoparticles to
oscillate or “dance” giving off heat and killing cancer cells.
Using this exact principle, Vaishnava and his research team (Professor Ron Kumon and
students Nathaniel Mosher and Emily Perkins) have expanded on this technique by
attaching anti-cancer drugs to the magnetic nanoparticles. Once the magnetic
nanoparticles reach the cancer site, the drugs are released right on to the cancer site in
the eye.
“There are so many aspects to it,” Vaishnava said. “Although the principle looks very
simple, when you start using it, there are so many challenges.”
Going one step further, Vaishnava has plans to use “microbubbles” that are 1,000 times
bigger than magnetic nanoparticles. Each “microbubble” is surrounded by magnetic
nanoparticles and can burst with ultrasound to unleash a large concentrated amount of
medication and nanoparticles at the cancer site.
“We took retinoblastoma cancer cells and mixed them with magnetic nanoparticles in a
petri dish, not even a microbubble, and we heated them at 42 degrees Celsius for three
minutes and were surprised with the results - we killed 90 percent of the cancer cells.”

Next Steps
Vaishnava in partnership with Demirci at the Kellogg Eye Center is seeking funding for
Phase II trial which will involve treating mice with ocular cancers. In the future, Phase III
trial will involve humans.
“We are really excited because not only can we heat and kill cancer cells but we can
deliver the drugs,” Vaishnava said. “Our procedure is a combination of limited
chemotherapy and hyperthermia.”
What is the greatest benefit of magnetic nanoparticle treatment? There are no side
effects.
“Because this is just heat, for human beings, they might feel some sensation of warmth
at the site of the tumor,” Vaishnava said.
Despite the concentrated and precise nature of the treatment, Vaishnava suggests that
magnetic nanoparticle treatment will be most effective when combined with traditional
forms of therapies such as radiation and chemotherapy in order to ensure that cancer
cells aren’t lingering in other parts of the body. A tandem approach to treatment can
also have complementary results.
“There are some tumors which are resistant to radiation and chemotherapy. This is
because of their hypoxic nature.” Vaishnava said. “By heating the tumor, we can
increase the profusion rate increasing the amount of oxygen in the tumor. Both
radiation and chemotherapy have a greater impact when there’s rich oxygenated blood
flow to the cancer site.”
For now, Vaishnava and his colleagues will continue to perfect the science and
techniques as they proceed through the various phases before this technique receives
widespread approval for use in the United States.
“There’s a great demand for this kind of work. This is a step forward in melanoma and
retinoblastoma treatment,” Vaishnava said.

Written By Pardeep Toor | Contact: Patrick Hayes - phayes@kettering.edu - (810)
762-9639
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Researchers at Kettering
University and the
University of Michigan
Kellogg Eye Center are
finding early success in
developing a treatment
that kills ocular cancer
cells without using
chemotherapy or
radiation.
“The science is there and
there’s proof that it works,” says Prem Vaishnava, professor of physics at Kettering University
in Flint, who is working on the project with Dr. Hakan Demirci at UM in Ann Arbor.
Vaishnava says the technique is now being used in Europe, but has not been approved in the
United States.
The treatment uses magnetic nanoparticles — iron oxide molecules that are suspended in a
solution and can be injected into the body or directly into a tumor — to target Chorodial
Melanoma and Retinoblastoma, both cancers of the eye.
http://www.dbusiness.com/dailynews/Annual2014/KetteringUMResearchersTreatingOcularCancerwithoutRadiation/
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“Phase I and Phase II trials have been conducted successfully using magnetic nanoparticles in
animals in the United States," Vaishnava says.
Once injected, magnetic nanoparticles can be guided to the cancer in the eye by using a
magnet positioned around the given area. Once they are concentrated around the cancer site,
a magnetic field can be applied, causing the nanoparticles to oscillate and give off heat,
thereby killing cancer cells.
The researchers have expanded the technique by attaching anticancer drugs to the magnetic
nanoparticles. Once the magnetic nanoparticles reach the cancer site, the drugs are released
right on to the cancer site in the eye.
Vaishnava says future plans are to use microbubbles, which are 1,000 times bigger than
magnetic nanoparticles, in the tests. Each microbubble is surrounded by magnetic
nanoparticles and can burst with ultrasound to release a large, concentrated amount of
medication and nanoparticles at the cancer site.
“We took retinoblastoma cancer cells and mixed them with magnetic nanoparticles in a petri
dish, not even a microbubble, and we heated them at 42 degrees Celsius for three minutes
and were surprised with the results — we killed 90 percent of the cancer cells,” he says.
The researchers are seeking funding for Phase II trials, which will involve treating mice with
ocular cancers. In the future, Phase III trial will involve humans.
This article appears in the Annual 2014 issue of Daily News
Did you like what you read here? Subscribe to Daily News »
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Kettering University professor helps develop new technique to
fight ocular cancer
Sarah Schuch | sschuch@mlive.com By Sarah Schuch | sschuch@mlive.com
on November 12, 2014 at 1:00 PM, updated November 12, 2014 at 2:07 PM
FLINT, MI -- One Kettering University
professor hopes to change the way the health

Kettering professor Prem Vaishnava is working on a new technique to
treat ocular cancer that doesn't require radiation or chemotherapy.
Courtesy of Kettering University

community looks at treatment for ocular
cancer.
Prem Vaishnava, Kettering physics professor, partnered with Hakan Demirci at the University of Michigan
Kellogg Eye Center to develop a new technique to fight ocular cancer without the use of radiation or
chemotherapy.
The treatment uses magnetic nanoparticles and magnetic microbubbles to specifically target Chorodial
Melanoma and Retinoblastoma – both cancers of the eye.
So far in 2014 there have been 2,730 new cases of cancers of the eye and orbit in the United States -- 1,440 in
men and 1,290 in women -- according to the American Cancer Society.
There has been 310 deaths from cancers of the eye and orbit so far this year, according to the American Cancer
Society's website.
This technique being tested by Vaishnava and Demirci is currently being used to treat cancer in humans in
Europe but has not yet been approved in the United States, according to a release.
"The science is there and there's proof that it works. Phase I and Phase II trials have been conducted
successfully using magnetic nanoparticles in animals in the United States," Vaishnava said in a written
statement.
How does it work?
In a simple experiment, retinoblastoma cancer cells were mixed with magnetic nanoparticles in a petri dish and
the mixture was exposed to an alternating magnetic field of frequency 350 kHz. The magnetic nanoparticles
produced heat which was sufficient to kill cancer cells and the healthy cells remain unharmed.
Using that same principle, Vaishnava and his research team have expanded on the technique by attaching drugs
to a magnet and then guiding that magnet to another magnet underneath the eye.
http://blog.mlive.com/newsnow_impact/print.html?entry=/2014/11/kettering_university_professor_14.html
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The drugs are released right on to the cancer site in the eye.
Now the team hopes to move forward in the research.
Vaishnava in partnership with Demirci at the Kellogg Eye Center is seeking funding for Phase II trial which will
involve treating mice with ocular cancers. In the future, Phase III trial will involve humans.
"There's a great demand for this kind of work. This is a step forward in melanoma and retinoblastoma
treatment," Vaishnava said in a written statement.
© 2014 MLive.com. All rights reserved.
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Excerpt from University of Michigan Kellogg Eye Center 2014‒15 Annual Report,
“Collaborations in ocular oncology: Using thermal energy to eliminate side effects in eye cancer
therapies,” p. 15, available at
http://issuu.com/u-mkelloggeyecenter/docs/ar_2014_055b4d66b24bfc?e=6943966/10813102

